Double Deletion of Angiotensin II Type 2 and Mas Receptors Accelerates Aging‐Related Muscle Weakness in Male Mice

Background The activation of AT2 (angiotensin II type 2 receptor ) and Mas receptor by angiotensin II and angiotensin‐(1‐7), respectively, is the primary process that counteracts activation of the canonical renin‐angiotensin system (RAS). Although inhibition of canonical RAS could delay the progress...

Full description

Bibliographic Details
Main Authors: Hikari Takeshita, Koichi Yamamoto, Masaki Mogi, Yu Wang, Yoichi Nozato, Taku Fujimoto, Serina Yokoyama, Kazuhiro Hongyo, Futoshi Nakagami, Hiroshi Akasaka, Yoichi Takami, Yasushi Takeya, Ken Sugimoto, Masatsugu Horiuchi, Hiromi Rakugi
Format: Article
Language:English
Published: Wiley 2021-07-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.120.021030
_version_ 1828046306726117376
author Hikari Takeshita
Koichi Yamamoto
Masaki Mogi
Yu Wang
Yoichi Nozato
Taku Fujimoto
Serina Yokoyama
Kazuhiro Hongyo
Futoshi Nakagami
Hiroshi Akasaka
Yoichi Takami
Yasushi Takeya
Ken Sugimoto
Masatsugu Horiuchi
Hiromi Rakugi
author_facet Hikari Takeshita
Koichi Yamamoto
Masaki Mogi
Yu Wang
Yoichi Nozato
Taku Fujimoto
Serina Yokoyama
Kazuhiro Hongyo
Futoshi Nakagami
Hiroshi Akasaka
Yoichi Takami
Yasushi Takeya
Ken Sugimoto
Masatsugu Horiuchi
Hiromi Rakugi
author_sort Hikari Takeshita
collection DOAJ
description Background The activation of AT2 (angiotensin II type 2 receptor ) and Mas receptor by angiotensin II and angiotensin‐(1‐7), respectively, is the primary process that counteracts activation of the canonical renin‐angiotensin system (RAS). Although inhibition of canonical RAS could delay the progression of physiological aging, we recently reported that deletion of Mas had no impact on the aging process in mice. Here, we used male mice with a deletion of only AT2 or a double deletion of AT2 and Mas to clarify whether these receptors contribute to the aging process in a complementary manner, primarily by focusing on aging‐related muscle weakness. Methods and Results Serial changes in grip strength of these mice up to 24 months of age showed that AT2/Mas knockout mice, but not AT2 knockout mice, had significantly weaker grip strength than wild‐type mice from the age of 18 months. AT2/Mas knockout mice exhibited larger sizes, but smaller numbers and increased frequency of central nucleation (a marker of aged muscle) of single skeletal muscle fibers than AT2 knockout mice. Canonical RAS‐associated genes, inflammation‐associated genes, and senescence‐associated genes were highly expressed in skeletal muscles of AT2/Mas knockout mice. Muscle angiotensin II content increased in AT2/Mas knockout mice. Conclusions Double deletion of AT2 and Mas in mice exaggerated aging‐associated muscle weakness, accompanied by signatures of activated RAS, inflammation, and aging in skeletal muscles. Because aging‐associated phenotypes were absent in single deletions of the receptors, AT2 and Mas could complement each other in preventing local activation of RAS during aging.
first_indexed 2024-04-10T18:24:27Z
format Article
id doaj.art-553dd448b1d244648ed1c40ad46f723a
institution Directory Open Access Journal
issn 2047-9980
language English
last_indexed 2024-04-10T18:24:27Z
publishDate 2021-07-01
publisher Wiley
record_format Article
series Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
spelling doaj.art-553dd448b1d244648ed1c40ad46f723a2023-02-02T06:18:05ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802021-07-01101310.1161/JAHA.120.021030Double Deletion of Angiotensin II Type 2 and Mas Receptors Accelerates Aging‐Related Muscle Weakness in Male MiceHikari Takeshita0Koichi Yamamoto1Masaki Mogi2Yu Wang3Yoichi Nozato4Taku Fujimoto5Serina Yokoyama6Kazuhiro Hongyo7Futoshi Nakagami8Hiroshi Akasaka9Yoichi Takami10Yasushi Takeya11Ken Sugimoto12Masatsugu Horiuchi13Hiromi Rakugi14Department of Geriatric and General Medicine Osaka University Graduate School of Medicine Suita JapanDepartment of Geriatric and General Medicine Osaka University Graduate School of Medicine Suita JapanDepartment of Pharmacology Ehime University Graduate School of Medicine Ehime JapanDepartment of Geriatric and General Medicine Osaka University Graduate School of Medicine Suita JapanDepartment of Geriatric and General Medicine Osaka University Graduate School of Medicine Suita JapanDepartment of Geriatric and General Medicine Osaka University Graduate School of Medicine Suita JapanDepartment of Geriatric and General Medicine Osaka University Graduate School of Medicine Suita JapanDepartment of Geriatric and General Medicine Osaka University Graduate School of Medicine Suita JapanDepartment of Geriatric and General Medicine Osaka University Graduate School of Medicine Suita JapanDepartment of Geriatric and General Medicine Osaka University Graduate School of Medicine Suita JapanDepartment of Geriatric and General Medicine Osaka University Graduate School of Medicine Suita JapanDepartment of Geriatric and General Medicine Osaka University Graduate School of Medicine Suita JapanDepartment of Geriatric and General Medicine Osaka University Graduate School of Medicine Suita JapanDepartment of Molecular Cardiovascular Biology and Pharmacology Ehime University Graduate School of Medicine Ehime JapanDepartment of Geriatric and General Medicine Osaka University Graduate School of Medicine Suita JapanBackground The activation of AT2 (angiotensin II type 2 receptor ) and Mas receptor by angiotensin II and angiotensin‐(1‐7), respectively, is the primary process that counteracts activation of the canonical renin‐angiotensin system (RAS). Although inhibition of canonical RAS could delay the progression of physiological aging, we recently reported that deletion of Mas had no impact on the aging process in mice. Here, we used male mice with a deletion of only AT2 or a double deletion of AT2 and Mas to clarify whether these receptors contribute to the aging process in a complementary manner, primarily by focusing on aging‐related muscle weakness. Methods and Results Serial changes in grip strength of these mice up to 24 months of age showed that AT2/Mas knockout mice, but not AT2 knockout mice, had significantly weaker grip strength than wild‐type mice from the age of 18 months. AT2/Mas knockout mice exhibited larger sizes, but smaller numbers and increased frequency of central nucleation (a marker of aged muscle) of single skeletal muscle fibers than AT2 knockout mice. Canonical RAS‐associated genes, inflammation‐associated genes, and senescence‐associated genes were highly expressed in skeletal muscles of AT2/Mas knockout mice. Muscle angiotensin II content increased in AT2/Mas knockout mice. Conclusions Double deletion of AT2 and Mas in mice exaggerated aging‐associated muscle weakness, accompanied by signatures of activated RAS, inflammation, and aging in skeletal muscles. Because aging‐associated phenotypes were absent in single deletions of the receptors, AT2 and Mas could complement each other in preventing local activation of RAS during aging.https://www.ahajournals.org/doi/10.1161/JAHA.120.021030agingangiotensin II type 2 receptorMas receptormusclerenin‐angiotensin system
spellingShingle Hikari Takeshita
Koichi Yamamoto
Masaki Mogi
Yu Wang
Yoichi Nozato
Taku Fujimoto
Serina Yokoyama
Kazuhiro Hongyo
Futoshi Nakagami
Hiroshi Akasaka
Yoichi Takami
Yasushi Takeya
Ken Sugimoto
Masatsugu Horiuchi
Hiromi Rakugi
Double Deletion of Angiotensin II Type 2 and Mas Receptors Accelerates Aging‐Related Muscle Weakness in Male Mice
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
aging
angiotensin II type 2 receptor
Mas receptor
muscle
renin‐angiotensin system
title Double Deletion of Angiotensin II Type 2 and Mas Receptors Accelerates Aging‐Related Muscle Weakness in Male Mice
title_full Double Deletion of Angiotensin II Type 2 and Mas Receptors Accelerates Aging‐Related Muscle Weakness in Male Mice
title_fullStr Double Deletion of Angiotensin II Type 2 and Mas Receptors Accelerates Aging‐Related Muscle Weakness in Male Mice
title_full_unstemmed Double Deletion of Angiotensin II Type 2 and Mas Receptors Accelerates Aging‐Related Muscle Weakness in Male Mice
title_short Double Deletion of Angiotensin II Type 2 and Mas Receptors Accelerates Aging‐Related Muscle Weakness in Male Mice
title_sort double deletion of angiotensin ii type 2 and mas receptors accelerates aging related muscle weakness in male mice
topic aging
angiotensin II type 2 receptor
Mas receptor
muscle
renin‐angiotensin system
url https://www.ahajournals.org/doi/10.1161/JAHA.120.021030
work_keys_str_mv AT hikaritakeshita doubledeletionofangiotensiniitype2andmasreceptorsacceleratesagingrelatedmuscleweaknessinmalemice
AT koichiyamamoto doubledeletionofangiotensiniitype2andmasreceptorsacceleratesagingrelatedmuscleweaknessinmalemice
AT masakimogi doubledeletionofangiotensiniitype2andmasreceptorsacceleratesagingrelatedmuscleweaknessinmalemice
AT yuwang doubledeletionofangiotensiniitype2andmasreceptorsacceleratesagingrelatedmuscleweaknessinmalemice
AT yoichinozato doubledeletionofangiotensiniitype2andmasreceptorsacceleratesagingrelatedmuscleweaknessinmalemice
AT takufujimoto doubledeletionofangiotensiniitype2andmasreceptorsacceleratesagingrelatedmuscleweaknessinmalemice
AT serinayokoyama doubledeletionofangiotensiniitype2andmasreceptorsacceleratesagingrelatedmuscleweaknessinmalemice
AT kazuhirohongyo doubledeletionofangiotensiniitype2andmasreceptorsacceleratesagingrelatedmuscleweaknessinmalemice
AT futoshinakagami doubledeletionofangiotensiniitype2andmasreceptorsacceleratesagingrelatedmuscleweaknessinmalemice
AT hiroshiakasaka doubledeletionofangiotensiniitype2andmasreceptorsacceleratesagingrelatedmuscleweaknessinmalemice
AT yoichitakami doubledeletionofangiotensiniitype2andmasreceptorsacceleratesagingrelatedmuscleweaknessinmalemice
AT yasushitakeya doubledeletionofangiotensiniitype2andmasreceptorsacceleratesagingrelatedmuscleweaknessinmalemice
AT kensugimoto doubledeletionofangiotensiniitype2andmasreceptorsacceleratesagingrelatedmuscleweaknessinmalemice
AT masatsuguhoriuchi doubledeletionofangiotensiniitype2andmasreceptorsacceleratesagingrelatedmuscleweaknessinmalemice
AT hiromirakugi doubledeletionofangiotensiniitype2andmasreceptorsacceleratesagingrelatedmuscleweaknessinmalemice